歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

交易中 12-22 15:44:30

12.630

-0.370

-2.85%

最高12.650	最低12.010	成交量275.60万
今开12.500	昨收13.000	日振幅4.92%
总市值125.29亿	流通市值125.29亿	总股本9.92亿
成交额3,416万	换手率0.28%	流通股本9.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":12.63,"timestamp":1766389464289,"preClose":13,"halted":0,"volume":2756000,"delay":0,"floatShares":992000000,"shares":992000000,"eps":-0.3322947640501879,"marketStatus":"交易中","change":-0.37,"latestTime":"12-22 15:44:30","open":12.5,"high":12.65,"low":12.01,"amount":34157002,"amplitude":0.049231,"askPrice":12.63,"askSize":23000,"bidPrice":12.46,"bidSize":22000,"shortable":3,"etf":0,"ttmEps":-0.29340586514153255,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1766391000000},"marketStatusCode":2,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":13,"openAndCloseTimeList":[[1766367000000,1766376000000],[1766379600000,1766390400000]],"volumeRatio":0.650885,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"1130644400","title":"歌礼制药（01672）更新翌日披露报表，回购20万股股份，总额约255.86万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130644400","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130644400?lang=zh_cn&edition=full","pubTime":"2025-12-19 18:26","pubTimestamp":1766139965,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2025年12月19日发布翌日披露报表，公告当日通过香港交易所回购股份200,000股，约占当日已发行股本的0.0202%。此次回购的价格区间为每股12.39港元至12.99港元，总对价约2,558,560港元。根据公告，截至2025年12月19日，公司已发行股本仍为991,874,320股，库藏股数量为7,084,210股。公司回购授权决议于2025年5月22日获得通过，最多可回购96,284,628股。公司同时确认，此次交易已遵守香港联合交易所有限公司证券上市规则及其他适用规例，公告由公司秘书钟明辉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"2592903469","title":"歌礼制药-B(01672)12月18日斥资253.86万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903469","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592903469?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:17","pubTimestamp":1766060221,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月18日斥资253.86万港元回购20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251218/31875436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01477","BK1191","BK1161","BK1515","BK1574","01672"],"gpt_icon":0},{"id":"2592514974","title":"每日卖空追踪 | 歌礼制药-B 12月18日卖空量成交21.7万股，卖空比例为11.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592514974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592514974?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046622,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月18日，跌3.81%，卖空量成交21.7万股，较上一交易日减少6.06%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163314a45aa164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163314a45aa164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01672","01477","BK1574","BK1161"],"gpt_icon":0},{"id":"2592974571","title":"歌礼制药-B盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592974571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592974571?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:33","pubTimestamp":1766021597,"startTime":"0","endTime":"0","summary":"2025年12月18日早盘09时33分，歌礼制药-B股票出现异动，股价大幅下挫5.33%。截至发稿，该股报12.430港元/股，成交量9.6万股，换手率0.01%，振幅5.86%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，科伦博泰生物-B、派格生物医药-B、基石药业-B涨幅较大，振幅较大的相关个股有歌礼制药-B、圣诺医药-B、拨康视云-B，振幅分别为5.26%、4.96%、4.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093317953b66cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218093317953b66cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01477","01672","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"2592434947","title":"智通港股回购统计|12月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2592434947","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592434947?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:10","pubTimestamp":1766020202,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量105.70 万，回购金额6.36 亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02299","03888","06186","02038","01024","00345","00732","00386","02018","02869","00669","00434","03798","06608","01458","09857","00909","01317","01773","09959","06100","09878","02158","01919","06078","02251","06826","01681","01588","02416","02419","01066","02171","00947","02319","00383","02369","00700","00175","01951","02367","01995","01672","02167","02517","09886","02273","06098","02598","01651"],"gpt_icon":1},{"id":"1115188443","title":"歌礼制药（01672）更新翌日披露报表，回购20万股股份，总额约260万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115188443","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115188443?lang=zh_cn&edition=full","pubTime":"2025-12-17 17:36","pubTimestamp":1765964171,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2025年12月17日发布翌日披露报表。公告显示，公司当日于香港联交所回购20万股普通股，最高回购价每股13.17港元，最低回购价每股12.55港元，合计付出约260.115万港元。该回购股份占公司现有已发行股本约0.0202%。截至本次回购后，累计在交易所回购4,986,000股，占授权通过当日已发行股份总数的约0.5174%。根据公告，公司确认上述回购行为符合香港联合交易所有限公司证券上市规则及相关法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"gpt_icon":0},{"id":"2592695160","title":"智通港股回购统计|12月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2592695160","media":"智通财经","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592695160?lang=zh_cn&edition=full","pubTime":"2025-12-17 09:10","pubTimestamp":1765933801,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量106.70 万，回购金额6.36 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02392","01907","02319","01651","01810","02171","01672","02866","01066","00345","06608","09886","02018","02369","00732","06868","02598","02251","03899","01317","08149","09959","00386","02869","06100","00909","00434","01588","02219","02367","09878","00669","01773","00700","01995","02416","01681","02038","06098","01458","00947","01024","03888","02273","01919","02678","02419","02158","02299","00175"],"gpt_icon":1},{"id":"2591989723","title":"歌礼制药-B(01672)12月16日斥资260.99万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591989723","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591989723?lang=zh_cn&edition=full","pubTime":"2025-12-16 20:03","pubTimestamp":1765886631,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年12月16日斥资260.99万港元回购20万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1191","BK1515","BK1574","01477","BK1161"],"gpt_icon":0},{"id":"2592931390","title":"2026年一个注定燃爆的BD方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2592931390","media":"药渡Daily","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592931390?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:30","pubTimestamp":1765877458,"startTime":"0","endTime":"0","summary":"司美格鲁肽原研由诺和诺德开发，但随着其核心专利将于2026年3月到期，中国市场正在上演激烈的司美格鲁肽生物类似药争夺战。截至目前，国内已有10款国产司美格鲁肽申报上市，并有10款已进入临床III期阶段。展望减重领域的下一个BD热点，三靶点GLP-1或是其中之一。全球口服小分子GLP-1R激动剂研发管线（部分）图源：国金证券研报展望2026年，减脂不减肌药物、小核酸减重药物有望成为下一个BD“金矿”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216184301a6a93b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216184301a6a93b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","06887","BK1515","01541","BK1574","02105"],"gpt_icon":0},{"id":"2592361931","title":"每日卖空追踪 | 歌礼制药-B 12月16日卖空量成交12.5万股，卖空比例为1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592361931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592361931?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873821,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月16日，涨0.08%，卖空量成交12.5万股，较上一交易日减少37.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163323a4519de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163323a4519de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","BK1191","BK1574","01477","BK1515"],"gpt_icon":0},{"id":"2591867976","title":"港股异动 | 歌礼制药-B(01672)回暖近3% IL-17抑制剂ASC50美国I期研究取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2591867976","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591867976?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:53","pubTimestamp":1765850029,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B回暖近3%，截至发稿，涨2.01%，报13.2港元，成交额3184.24万港元。消息面上，12月15日，歌礼制药-B发布公告，ASC50在美国开展的一项随机、双盲、安慰剂对照的I期临床试验取得积极顶线结果，该试验是在健康受试者中进行的单剂量递增研究，旨在评估ASC50的安全性、耐受性、药代动力学及外周循环的白细胞介素-17A靶向结合特征。46名健康受试者接受了10毫克、30毫克、100毫克、200毫克、400毫克或600毫克ASC50，或匹配的安慰剂给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1191","01672","BK1161","01477"],"gpt_icon":0},{"id":"1122759110","title":"歌礼制药-B公布美国I期研究Asc50的积极顶线结果，这是一种潜在的最佳口服小分子IL-17抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1122759110","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122759110?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:00","pubTimestamp":1765789225,"startTime":"0","endTime":"0","summary":"歌礼制药-B公布了美国I期研究Asc50的积极顶线结果，这是一种潜在的最佳口服小分子IL-17抑制剂","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01672","BK1515"],"gpt_icon":0},{"id":"2591116096","title":"歌礼制药-B(01672)：有望成为同类最佳口服小分子IL-17抑制剂ASC50美国I期研究取得积极的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2591116096","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591116096?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:49","pubTimestamp":1765788597,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，ASC50在美国开展的一项随机、双盲、安慰剂对照的I期临床试验取得积极顶线结果，该试验是在健康受试者中进行的单剂量递增研究，旨在评估ASC50的安全性、耐受性、药代动力学及外周循环的白细胞介素-17A靶向结合特征。ASC50为歌礼自主研发的口服小分子IL-17靶向抑制剂，IL-17在银屑病等多种自身免疫及炎症性疾病中已获充分的生物学验证并具备成熟商业价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK1574","BK1191","01477","BK1515","BK1161"],"gpt_icon":0},{"id":"1145036786","title":"港股异动 | 生物技术概念股走低，歌礼制药-B跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145036786","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145036786?lang=zh_cn&edition=full","pubTime":"2025-12-15 11:30","pubTimestamp":1765769431,"startTime":"0","endTime":"0","summary":"12月15日，港生物技术概念股走低，$歌礼制药-B(01672)$跌超8%，$圣诺医药-B(02257)$、$复宏汉霖(02696)$、$百济神州(06160)$跌超6%.","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f81ff915a0c110277ba56cf9ecd1a11a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","01672","BK1161","BK1191"],"gpt_icon":0},{"id":"2591956296","title":"港股开盘 | 恒指低开1% 医药板块跌幅居前 歌礼制药(01672)跌超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591956296","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591956296?lang=zh_cn&edition=full","pubTime":"2025-12-15 09:30","pubTimestamp":1765762255,"startTime":"0","endTime":"0","summary":"恒生指数低开1%，恒生科技指数跌1.34%。盘面上，辅助生殖概念活跃，三胎概念股锦欣生殖开涨约3%；医药板块跌幅居前，歌礼制药跌超5%。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20251215/20251215093112_33389.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251215/20251215093112_33389.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f81ff915a0c110277ba56cf9ecd1a11a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["MHImain","02833","01672","HSImain","HSI","BK1191","09939","01477","BK1161","513600","BK1574","BK4614","YANG","159938","MCHmain","HHImain","BK1515"],"gpt_icon":0},{"id":"2590570816","title":"歌礼制药-B(01672)12月12日耗资约437.38万港元回购30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590570816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590570816?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:21","pubTimestamp":1765534862,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)公布，2025年12月12日耗资约437.38万港元回购30万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","BK1191","01477","BK1161","01672"],"gpt_icon":0},{"id":"2590545341","title":"歌礼制药-B12月11日主力净流出132.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590545341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590545341?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:16","pubTimestamp":1765440965,"startTime":"0","endTime":"0","summary":"12月11日, 歌礼制药-B股价跌5.48%，报收15.00元，成交金额7920.3万元，换手率0.52%，振幅7.31%，量比0.40。歌礼制药-B今日主力资金净流出132.0万元，上一交易日主力净流入396.5万元。该股近5个交易日上涨16.20%，主力资金累计净流出3377.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入387.6万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162316a6990e12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162316a6990e12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1191","01477","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2590456613","title":"GLP-1市场争夺战：礼来替尔泊肽进医保，国产药如何冲出重围？","url":"https://stock-news.laohu8.com/highlight/detail?id=2590456613","media":"药经说","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590456613?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:30","pubTimestamp":1765359058,"startTime":"0","endTime":"0","summary":"事实上，作为全球大热的GLP-1药物，替尔泊肽此次进入医保，意味着成为继司美格鲁肽之后，第二个进入中国医保市场的进口GLP-1产品。竞争格局的急剧恶化是主因，礼来替尔泊肽在全球市场引发的市场热度，无疑盖过了司美格鲁肽，并且让GLP-1市场的天平发生了倾斜。2025年“双十一”期间，京东健康平台上的GLP-1药物成交额增长超过6倍，其中礼来的替尔泊肽排名第一。如今，替尔泊肽正式进入医保目录，无疑将对市场竞争者带来全新的压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210181144a72f8838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210181144a72f8838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","01672"],"gpt_icon":0},{"id":"2590300641","title":"歌礼制药-B(01672)：同类首创FASN抑制剂地尼法司他(ASC40)治疗痤疮的新药上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2590300641","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590300641?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:06","pubTimestamp":1765357565,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，董事会宣布同类首创、每日一次口服小分子脂肪酸合成酶抑制剂地尼法司他治疗中重度寻常性痤疮的新药上市申请获中国国家药监局受理。地尼法司他显示出了良好的安全性与耐受性特征。未有观察到与地尼法司他 相关的永久性终止治疗或煺出试验的情况。公司已于近期完成与中国国家药监局就地尼法司他治疗中重度寻常性痤疮的新药上市申请前沟通并收到国家药监局的积极反馈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1191","BK1515","01672","01477","BK1574"],"gpt_icon":0},{"id":"2590184566","title":"每日卖空追踪 | 歌礼制药-B 12月10日卖空量成交12.5万股，卖空比例为1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590184566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590184566?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355423,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间12月10日，跌6.15%，卖空量成交12.5万股，较上一交易日减少73.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163456a43f9ebd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210163456a43f9ebd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1191","01672","BK1161","01477"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.1047},{"period":"1month","weight":-0.0483},{"period":"3month","weight":0.2172},{"period":"6month","weight":0.3514},{"period":"1year","weight":4.2846},{"period":"ytd","weight":3.3189}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0054},{"period":"3month","weight":-0.0322},{"period":"6month","weight":0.0918},{"period":"1year","weight":0.3006},{"period":"ytd","weight":0.2807}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.058802},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.059274},{"month":5,"riseRate":0.428571,"avgChangeRate":0.007612},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.024499},{"month":7,"riseRate":0.571429,"avgChangeRate":0.032162},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.037953},{"month":9,"riseRate":0.125,"avgChangeRate":-0.072967},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023171},{"month":11,"riseRate":0.875,"avgChangeRate":0.185422},{"month":12,"riseRate":0.5,"avgChangeRate":0.101083}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}